GTx (United States)
GTx, Inc. was a pharmaceutical company working on drugs in the selective estrogen receptor modulator and selective androgen receptor modulator classes. Its drugs in development included enobosarm and GTx-758. The company was founded in Memphis in 1997 by Mitch Steiner and Marc S. Hanover. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for GTx (United States), United States, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
28%
Total
Publications
28K
Total Open
Publications
7.9K
Total
Citations
1.2M
Open Access
Percentage
28%
Total
Publications
28K
Total Open
Publications
7.9K
Total
Citations
1.2M
Breakdown
Publisher Open
12%
Both
9%
Other Platform Open
9%
Closed
70%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 35%
2.1K
Hybrid 25%
1.5K
No Guarantees 40%
2.3K
Other Platform Open
Domain 56%
2.9K
Institution 47%
2.4K
Other Internet 6%
304
Public 2%
121
Preprint 2%
106
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 2.9K |
doaj.org OAI-PMH Repository | Institution | 809 |
Unknown Repository | Other Internet | 167 |
DOI | Other Internet | 147 |
Royal Netherlands Academy of Arts and Sciences | Institution | 108 |
LA Referencia | Institution | 92 |
University of Groningen | Institution | 85 |
Figshare | Public | 85 |
Research Square | Preprint | 78 |
wur.nl OAI-PMH Repository | Institution | 68 |